retatrutide and liver STUDY: Novel “Triagonist” Resolved Steatosis in Over 85% of Patients with MASLD Obesity Retatrutide: Fat Loss, Liver Health
Description
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al
doi: 10.1007/s00125-020-05158-9
Many users describe simply forgetting to eat
Read it here: To view or add a comment, sign in Obesity as a metabolic disease is not a singlepathway problem Obesity is often discussed as a single disease with a single solution
serious kidney, stomach and gallbladder problems
But that is different from people with advanced liver disease or liver failure
